Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Feb 7, 2025
Open Peer Review Period: Feb 7, 2025 - Apr 4, 2025
Date Accepted: May 14, 2025
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Biases in Medicine and Artificial Intelligence: impact and inclusion of the trans people.
ABSTRACT
This paper carried out a research study on the perception and use of artificial intelligence (AI) for personalized medicine in transgender people. We applied the communicative methodology whose distinctive aspect is the active involvement of end-users and stakeholders through an egalitarian dialogue acknowledging cultural intelligence. During the design of the data collection-instruments, particularly in the elaboration of questions, multiple prior meetings with representatives of the trans community were organised to adapt the documents and co-create the workflow. Through the implementation of three focus groups, different problems and challenges that occur in the application of AI in the development of the precision medicine were discussed with trans adult people. The results show main obstacles that the participating people identified as well as possible solutions and proposed improvements. The work seeks to promote quality of life from a trans-inclusive and multidisciplinary perspective in a little-explored field of study.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.